RT Journal Article
SR Electronic
T1 Identifying At-Risk Communities and Key Vulnerability Indicators in the COVID-19 Pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.19.21263805
DO 10.1101/2021.09.19.21263805
A1 Thais, Savannah
A1 Leibowitz, Shaine
A1 Gutierrez, Alejandra Rios
A1 Passarelli, Alexandra
A1 Santo, Stephanie
A1 Shipp, Nora
YR 2021
UL http://medrxiv.org/content/early/2021/09/22/2021.09.19.21263805.abstract
AB Throughout the COVID-19 pandemic, certain communities have been disproportionately exposed to detrimental health outcomes and socioeconomic injuries. Quantifying community needs is crucial for identifying testing and service deserts, effectively allocating resources, and informing funding and decision making. We have constructed research-driven metrics measuring the public health and economic impacts of COVID-19 on vulnerable populations. In this work we further examine and validate these indices by training supervised models to predict proxy outcomes and analyzing the feature importances to identify gaps in our original metric design. The indices analyzed in this work are unique among COVID-19 risk assessments due to their robust integration of disparate data sources. Together, they enable more effective responses to COVID-19 driven health inequities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAll work is supported by Community Insight and ImpactAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We use only public source dataAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is all taken from open source databases